Balance Sheet
Cash Flow Statement
AcquisitionsCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in Net LoansDivestmentsDividends Paid - CommonDividends Paid - CommonExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Sales and DivestituresGains from Sales and DivestituresLong-Term Debt IssuancesNet Cash FlowNet Cash FlowNet IncomeOther financing activitiesOther financing activitiesSales of Property, Plant and EquipmentSales of Property, Plant and EquipmentShares IssuedShares RepurchasedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Nomura Holdings (NMR) Capital Expenditures (2016 - 2024)

Nomura Holdings has reported Capital Expenditures over the past 16 years, most recently at -$190.5 million for Q1 2024.

  • For Q1 2024, Capital Expenditures fell 107.98% year-over-year to -$190.5 million; the TTM value through Mar 2024 reached -$1.0 billion, down 174.62%, while the annual FY2026 figure was -$2.3 billion, 81.19% down from the prior year.
  • Capital Expenditures for Q1 2024 was -$190.5 million at Nomura Holdings, up from -$438.0 million in the prior quarter.
  • Over five years, Capital Expenditures peaked at $2.4 billion in Q1 2023 and troughed at -$627.3 million in Q4 2022.
  • A 5-year average of -$5.0 million and a median of -$215.9 million in 2023 define the central range for Capital Expenditures.
  • On a YoY basis, Capital Expenditures climbed as much as 497.49% in 2022 and fell as far as 248.05% in 2022.
  • Year by year, Capital Expenditures stood at -$248.7 million in 2020, then grew by 27.53% to -$180.2 million in 2021, then tumbled by 248.05% to -$627.3 million in 2022, then soared by 30.16% to -$438.0 million in 2023, then surged by 56.51% to -$190.5 million in 2024.
  • Business Quant data shows Capital Expenditures for NMR at -$190.5 million in Q1 2024, -$438.0 million in Q4 2023, and -$215.9 million in Q3 2023.